"Gum Disease Treatment Linked to Reduced Risk of Recurring A-Fib"
Japanese research suggests that treating gum disease within three months of catheter heart ablation may reduce the recurrence of atrial fibrillation (AFib). The study of 288 patients found a strong correlation between gum inflammation and AFib recurrence, leading to a call for routine examination of AFib patients for gum disease. The findings could have significant implications for healthcare, as AFib is expected to affect over 12 million Americans by 2030, and around half of U.S. adults aged 30 and up have some form of gum disease. The study highlights the potential benefits of managing gum disease for improving the prognosis of AFib.
